GlobeNewswire Inc | Nov 9, 2021 06:30AM EST

November 09, 2021

HEIDELBERG, Germany, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that management will present and host one-on-one meetings at the following investor conferences during the month of November 2021.

Stifel 2021 Virtual Healthcare Conference (November 15 - 17, 2021)Date: Monday, November 15, 2021Presentation Time: 8:00 a.m. ESTWebcast: https://www.affimed.com/investors/webcasts_cp/Location: Virtual

Jefferies London Healthcare Conference 2021 (November 16 - 19, 2021)Date: Friday, November 19, 2021Presentation Time: The Fireside Chat will become available on November 18 at 3:00 a.m. ESTWebcast: https://www.affimed.com/investors/webcasts_cp/Location: Virtual

For more information on the conferences or to schedule a one-on-one meeting with Affimed management, please contact your conference representative or Alex Fudukidis via email at a.fudukidis@affimed.com or phone at +1 (917) 436-8102.

About Affimed N.V.Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The companys proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK platform predictably generates customized innate cell engager (ICE) molecules, which use patients immune cells to destroy tumor cells. This innovative approach enabled Affimed to become the first company with a clinical-stage ICE. Headquartered in Heidelberg, Germany, with offices in New York, NY, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by a bold vision to stop cancer from ever derailing patients lives. For more about the companys people, pipeline and partners, please visit: https://www.affimed.com.

Affimed Investor ContactAlexander FudukidisDirector, Head of Investor RelationsE-Mail: a.fudukidis@affimed.comTel.: +1 (917) 436-8102